Luminal A has a poor prognosis.

Prepare for the CMID Test. Study with flashcards and multiple choice questions, each question contains hints and explanations. Get ready for your exam with confidence!

Multiple Choice

Luminal A has a poor prognosis.

Explanation:
Luminal A breast cancers are typically ER-positive and HER2-negative with low proliferation (low Ki-67) and often PR-positive. This combination means tumors grow more slowly and respond well to endocrine therapies like tamoxifen or aromatase inhibitors. Because they behave less aggressively and are more hormone-driven, their risk of early recurrence is lower than that of other subtypes, leading to a generally favorable prognosis. So the statement that Luminal A has a poor prognosis is not correct. Keep in mind that prognosis can vary with stage, grade, and other factors, but Luminal A classically carries the best outlook among the intrinsic subtypes.

Luminal A breast cancers are typically ER-positive and HER2-negative with low proliferation (low Ki-67) and often PR-positive. This combination means tumors grow more slowly and respond well to endocrine therapies like tamoxifen or aromatase inhibitors. Because they behave less aggressively and are more hormone-driven, their risk of early recurrence is lower than that of other subtypes, leading to a generally favorable prognosis. So the statement that Luminal A has a poor prognosis is not correct. Keep in mind that prognosis can vary with stage, grade, and other factors, but Luminal A classically carries the best outlook among the intrinsic subtypes.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy